CEA, DSV, IRCM, SREIT, Laboratoire de Cancérologie Expérimentale, BP6, Fontenay-aux-Roses, F-92265, France.
Institut Gustave Roussy, Department on Nuclear Medicine and Endocrine Oncology, Villejuif, and University Paris-Sud, F-94800, France.
Genes (Basel). 2011 Dec 21;3(1):19-34. doi: 10.3390/genes3010019.
Both external radiation exposure and internal radionuclide contamination are well known risk factors in the development of thyroid epithelial tumors. The identification of specific molecular markers deregulated in radiation-induced thyroid tumors is important for the etiological diagnosis since neither histological features nor genetic alterations can discriminate between sporadic and radiation-induced tumors. Identification of highly discriminating markers in radiation-induced tumors is challenging as it relies on the ability to identify marker deregulation which is associated with a cellular stress that occurred many years before in the thyroid cells. The existence of such a signature is still controversial, as it was not found in several studies while a highly discriminating signature was found in both post-radiotherapy and post-Chernobyl series in other studies. Overall, published studies searching for radiation-induced thyroid tumor specificities, using transcriptomic, proteomic and comparative genomic hybridization approaches, and bearing in mind the analytical constraints required to analyze such small series of tumors, suggest that such a molecular signature could be found. In comparison with sporadic tumors, we highlight molecular similarities and specificities in tumors occurring after high-dose external radiation exposure, such as radiotherapy, and in post-Chernobyl tumors that occurred after internal 131I contamination. We discuss the relevance of signature extrapolation from series of tumors developing after high and low doses in the identification of tumors induced at very low doses of radiation.
外照射辐射和内放射性核素污染都是甲状腺上皮肿瘤发生的已知危险因素。鉴定放射性诱导甲状腺肿瘤中失调的特定分子标志物对于病因诊断很重要,因为组织学特征或遗传改变都不能区分散发性和放射性诱导肿瘤。在放射性诱导肿瘤中鉴定高度区分的标志物具有挑战性,因为它依赖于识别与多年前甲状腺细胞中发生的细胞应激相关的标记物失调的能力。这种特征的存在仍然存在争议,因为在一些研究中没有发现,而在其他研究中,在放射性治疗后和切尔诺贝利事件后系列中发现了高度区分的标志物。总的来说,使用转录组学、蛋白质组学和比较基因组杂交方法搜索放射性诱导甲状腺肿瘤特异性的已发表研究,并考虑到分析如此小系列肿瘤所需的分析限制,表明可能存在这样的分子特征。与散发性肿瘤相比,我们强调了在外照射辐射(如放疗)后和切尔诺贝利事件后内 131I 污染后发生的高剂量外部辐射暴露后发生的肿瘤中的分子相似性和特异性。我们讨论了从高剂量和低剂量后发展的肿瘤系列中推断特征对于鉴定极低剂量辐射诱导的肿瘤的相关性。